Harfst & Associates’s AbbVie ABBV Stock Holding History

Harfst & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$488K	Sell	2,631 -10	-0.4%	-$1.86K	0.1%	80
2025 Q1	$553K	Hold	2,641	–	–	0.13%	92
2024 Q4	$469K	Hold	2,641	–	–	0.1%	64
2024 Q3	$522K	Sell	2,641 -40	-1%	-$7.9K	0.12%	72
2024 Q2	$460K	Hold	2,681	–	–	0.11%	81
2024 Q1	$488K	Hold	2,681	–	–	0.12%	80
2023 Q4	$415K	Hold	2,681	–	–	0.11%	69
2023 Q3	$400K	Sell	2,681 -235	-8%	-$35K	0.11%	73
2023 Q2	$393K	Buy	2,916 +235	+9%	+$31.7K	0.1%	74
2023 Q1	$427K	Hold	2,681	–	–	0.12%	92
2022 Q4	$433K	Hold	2,681	–	–	0.13%	93
2022 Q3	$360K	Hold	2,681	–	–	0.11%	94
2022 Q2	$410K	Hold	2,681	–	–	0.12%	91
2022 Q1	$434K	Sell	2,681 -55	-2%	-$8.9K	0.1%	100
2021 Q4	$370K	Buy	2,736 +55	+2%	+$7.44K	0.09%	99
2021 Q3	$289K	Hold	2,681	–	–	0.08%	111
2021 Q2	$301K	Hold	2,681	–	–	0.09%	113
2021 Q1	$290K	Hold	2,681	–	–	0.09%	126
2020 Q4	$287K	Hold	2,681	–	–	0.11%	106
2020 Q3	$234K	Buy	2,681 +16	+0.6%	+$1.4K	0.1%	105
2020 Q2	$261K	Hold	2,665	–	–	0.11%	93
2020 Q1	$203K	Hold	2,665	–	–	0.1%	95
2019 Q4	$235K	Hold	2,665	–	–	0.09%	95
2019 Q3	$201K	Buy	+2,665	New	+$201K	0.08%	95
2019 Q2	–	Sell	-2,695	Closed	-$217K	–	94
2019 Q1	$217K	Hold	2,695	–	–	0.09%	94
2018 Q4	$248K	Hold	2,695	–	–	0.12%	80
2018 Q3	$254K	Hold	2,695	–	–	0.11%	75
2018 Q2	$249K	Hold	2,695	–	–	0.11%	73
2018 Q1	$255K	Buy	2,695 +475	+21%	+$44.9K	0.1%	72
2017 Q4	$214K	Buy	+2,220	New	+$214K	0.09%	80
2017 Q3	–	Sell	-2,220	Closed	-$160K	–	84
2017 Q2	$160K	Sell	2,220 -592	-21%	-$42.7K	0.06%	89
2017 Q1	$183K	Sell	2,812 -1,334	-32%	-$86.8K	0.08%	81
2016 Q4	$259K	Sell	4,146 -145	-3%	-$9.06K	0.13%	59
2016 Q3	$270K	Buy	4,291 +387	+10%	+$24.4K	0.14%	56
2016 Q2	$241K	Sell	3,904 -1,872	-32%	-$116K	0.1%	92
2016 Q1	$329K	Sell	5,776 -104	-2%	-$5.92K	0.21%	44
2015 Q4	$348K	Buy	5,880 +300	+5%	+$17.8K	0.14%	78
2015 Q3	$304K	Buy	5,580 +726	+15%	+$39.6K	0.13%	80
2015 Q2	$326K	Buy	+4,854	New	+$326K	0.18%	40